Abstract:Flurbiprofen (FPF), available commercially as a racemic mixture, is a propionic acid derivative of non-steroidal anti-inflammatory drugs (NSAIDs) with known stereoselective glucuronidation. The major enzyme catalyzing this conjugation reaction is UDP-glucuronosyltransferase (UGT) 2B7, with minor contributions by UGT1A9. This study examines the role of the genetic variants of UGT2B7 and 1A9 enzymes involved in the formation of acyl glucuronides (FPFGs). Variants caused by three single nucleotide polymorphisms (SNPs) (A71S, 211G>T; H268Y, 802C>T; and D398N, 1192G>A) in UGT2B7 and three SNPs (C3Y, 8G>A; M33T, 98T>C; D256N, 766G>A) in UGT1A9 showed activity changes toward different substrates. However the functional impacts of these SNPs on chiral substrates were not examined. Upon stable expression in Bac-to-Bac system, UGT2B7*71S (A(71)S), UGT2B7*2 (H(268)Y) and UGT2B7*5 (D(398)N) were all associated with a decrease in the formation of FPFGs. Compared with UGT2B7*1 (wild-type), UGT2B7*71S exhibited a >2-fold lower intrinsic clearance mainly by altered capacities (V(max)). Furthermore, a >14-fold decreased intrinsic clearance of the *1 protein was produced by UGT2B7*2 and UGT2B7*5. However, no significantly stereoselective difference for the formation of (R)- and (S)-FPFG was found among these UGT2B7 allozymes. UGT1A9*2 (C(3)Y) exhibited a higher V(max) (3.2-fold), K(m) (2.1-fold) and intrinsic clearance (1.6-fold) toward (S)-FPF than UGT1A9*1 (wild-type). UGT1A9*3 (M(33)T) almost lost the catalytic activity to FPF. A significantly stereoselective difference on the glucuronidation of rac-FPF was seen between the two variants compared with the wild type of UGT1A9.

Stereoselective Glucuronidation of Propafenone and Its Analogues by Human Recombinant Ugt1a9

Stereoselective Metabolism of Propranolol Glucuronidation by Human Udp-Glucuronosyltransferases 2b7 and 1A9

[Stereoselective Determination of Propranolol Enantiomer in Transgenic Cell Lines Expressing Human Cytochrome P450].

Study on the stereoselectivity of racemic propranolol glucuronidation metabolism

Complete Reaction Phenotyping of Propranolol and 4-Hydroxypropranolol with the 19 Enzymes of the Human UGT1 and UGT2 Families

Glucuronidation Pathways of 5- and 7-Hydroxypropranolol: Determination of Glucuronide Structures and Enzyme Selectivity

CHIRAL RP-HPLC ASSAY FOR PROPAFENONE ENANTIOMERS IN RAT LIVER MICROSOMAL INCUBATES AND ITS APPLICATION IN VITRO METABOLISM

Stereoselectivity and Interaction Between the Glucuronidation of S-(-)- and R-(+)-Propranolol in Rat Hepatic Microsomes Pretreated with Different Inducers

[Effects of Microsome Enzyme Induced by Phenobarbarbital on the Stereoselectivity of Recemic Propranolol Glucuronidation Metabolism].

Characterizing the Effect of UDP-glucuronosyltransferase (UGT) 2B7 and UGT1A9 Genetic Polymorphisms on Enantioselective Glucuronidation of Flurbiprofen.

Glucuronidation of apigenin by the recombinant human UGT1A3

Concentration Dependent Stereoselectivity of Propafenone N-depropylation Metabolism with Human Hepatic Recombinant CYP1A2.

Stereoselective Urinary Excretion of S-(-)- and R-(+)-Propranolol Glucuronide Following Oral Administration of Rs-Propranolol in Chinese Han Subjects

Effect of D256N and Y483D on propofol glucuronidation by human uridine 5'-diphosphate glucuronosyltransferase (UGT1A9)

Quantitative Regioselectivity of Glucuronidation of Quercetin by Recombinant UDP-glucuronosyltransferases 1A9 and 1A3 Using Enzymatic Kinetic Parameters

[Enatiomeric Separation of Beta-Blocking Agents and Analogs]

Stereoselective Metabolism of Propafenone by Human Liver CYP3A4 Expressed in Transgenic Chinese Hamster CHL Cells Lines.

Direct Determination of S-(-)- and R-(+)-propranolol Glucuronide in Rat Hepatic Microsomes by RP-HPLC.

HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY SEPARATION AND QUANTITATION OF PROPRANOLOL GLUCURONIDE IN RAT MICROSOMES

Glucuronidation of Flavonoids by Recombinant UGT1A3 and UGT1A9.

Stereoselective Determination of Propafenone Enantiomers in Transgenic Chinese Hamster CHL Cells Expressing Human Cytochrome P450.